[English] 日本語
Yorodumi- PDB-9fjf: Lysosomal transporting complex of beta-glucocerebrosidase (GCase)... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9fjf | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Lysosomal transporting complex of beta-glucocerebrosidase (GCase) and lysosomal integral membrane protein 2 (LIMP-2) with bound Pro-macrobodies (Combined focus map) | ||||||||||||||||||
Components |
| ||||||||||||||||||
Keywords | TRANSPORT PROTEIN / Parkinson / lysosome / Gaucher / GCase / SCARB2 / Pro-macrobody / Glucosylceramide / complex | ||||||||||||||||||
| Function / homology | Function and homology informationregulation of glucosylceramide catabolic process / regulation of carbohydrate catabolic process / regulation of endosome organization / steryl-beta-glucosidase activity / positive regulation of neuronal action potential / beta-glucoside catabolic process / cerebellar Purkinje cell layer formation / aminophospholipid transport / termination of signal transduction / galactosylceramidase ...regulation of glucosylceramide catabolic process / regulation of carbohydrate catabolic process / regulation of endosome organization / steryl-beta-glucosidase activity / positive regulation of neuronal action potential / beta-glucoside catabolic process / cerebellar Purkinje cell layer formation / aminophospholipid transport / termination of signal transduction / galactosylceramidase / galactosylceramidase activity / glucosylceramidase / scavenger receptor binding / lymphocyte migration / glucosylceramide catabolic process / regulation of lysosomal protein catabolic process / response to thyroid hormone / glucosylceramidase activity / sphingosine biosynthetic process / autophagosome organization / lysosomal protein catabolic process / microglial cell proliferation / glucosyltransferase activity / endosome to plasma membrane protein transport / regulation of lysosome organization / regulation of TOR signaling / protein targeting to lysosome / Glycosphingolipid catabolism / microglia differentiation / lipid storage / ceramide biosynthetic process / phosphatidylcholine binding / positive regulation of type 2 mitophagy / : / brain morphogenesis / Hydrolases; Glycosylases; Glycosidases, i.e. enzymes that hydrolyse O- and S-glycosyl compounds / response to pH / pyramidal neuron differentiation / cargo receptor activity / negative regulation of protein metabolic process / scavenger receptor activity / Transferases; Glycosyltransferases; Hexosyltransferases / lysosome organization / cholesterol binding / neuromuscular process / phosphatidylserine binding / response to dexamethasone / hematopoietic stem cell proliferation / antigen processing and presentation / response to testosterone / Association of TriC/CCT with target proteins during biosynthesis / motor behavior / negative regulation of interleukin-6 production / homeostasis of number of cells / regulation of macroautophagy / establishment of skin barrier / negative regulation of protein-containing complex assembly / cholesterol metabolic process / mitophagy / cell maturation / negative regulation of MAPK cascade / lysosomal lumen / receptor-mediated endocytosis / cellular response to starvation / determination of adult lifespan / respiratory electron transport chain / trans-Golgi network / clathrin-coated endocytic vesicle membrane / sensory perception of sound / positive regulation of neuron projection development / autophagy / negative regulation of inflammatory response / response to estrogen / cellular response to tumor necrosis factor / endocytic vesicle membrane / late endosome membrane / transmembrane signaling receptor activity / positive regulation of proteasomal ubiquitin-dependent protein catabolic process / Cargo recognition for clathrin-mediated endocytosis / T cell differentiation in thymus / Clathrin-mediated endocytosis / protein-folding chaperone binding / virus receptor activity / neuron apoptotic process / proteasome-mediated ubiquitin-dependent protein catabolic process / negative regulation of neuron apoptotic process / lysosome / endosome membrane / signaling receptor binding / Golgi membrane / lysosomal membrane / focal adhesion / endoplasmic reticulum membrane / enzyme binding / endoplasmic reticulum / Golgi apparatus / protein homodimerization activity / extracellular exosome / membrane / plasma membrane Similarity search - Function | ||||||||||||||||||
| Biological species | Homo sapiens (human)synthetic construct (others) | ||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3.7 Å | ||||||||||||||||||
Authors | Dobert, J.P. / Schaefer, J.H.S. / Dal Maso, T. / Socher, E. / Versees, W. / Moeller, A. / Zunke, F. / Arnold, P. | ||||||||||||||||||
| Funding support | United States, 5items
| ||||||||||||||||||
Citation | Journal: Nat Commun / Year: 2025Title: Cryo-TEM structure of β-glucocerebrosidase in complex with its transporter LIMP-2. Authors: Jan Philipp Dobert / Jan-Hannes Schäfer / Thomas Dal Maso / Priyadarshini Ravindran / Dustin J E Huard / Eileen Socher / Lisa A Schildmeyer / Raquel L Lieberman / Wim Versées / Arne ...Authors: Jan Philipp Dobert / Jan-Hannes Schäfer / Thomas Dal Maso / Priyadarshini Ravindran / Dustin J E Huard / Eileen Socher / Lisa A Schildmeyer / Raquel L Lieberman / Wim Versées / Arne Moeller / Friederike Zunke / Philipp Arnold / ![]() Abstract: Targeting proteins to their final cellular destination requires transport mechanisms and nearly all lysosomal enzymes reach the lysosome via the mannose-6-phosphate receptor pathway. One of the few ...Targeting proteins to their final cellular destination requires transport mechanisms and nearly all lysosomal enzymes reach the lysosome via the mannose-6-phosphate receptor pathway. One of the few known exceptions is the enzyme β-glucocerebrosidase (GCase) that requires the lysosomal integral membrane protein type-2 (LIMP-2) as a proprietary lysosomal transporter. Genetic variations in the GCase encoding gene GBA1 cause Gaucher's disease (GD) and present the highest genetic risk factor to develop Parkinson's disease (PD). Activators targeting GCase emerge as a promising therapeutic approach to treat GD and PD, with pre-clinical and clinical trials ongoing. In this study, we resolve the complex of GCase and LIMP-2 using cryo-electron microscopy with the aid of an engineered LIMP-2 shuttle and two GCase-targeted pro-macrobodies. We identify helix 5 and helix 7 of LIMP-2 to interact with a binding pocket in GCase, forming a mostly hydrophobic interaction interface supported by one essential salt bridge. Understanding the interplay of GCase and LIMP-2 on a structural level is crucial to identify potential activation sites and conceptualizing novel therapeutic approaches targeting GCase. Here, we unveil the protein structure of a mannose-6-phosphate-independent lysosomal transport complex and provide fundamental knowledge for translational clinical research to overcome GD and PD. | ||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9fjf.cif.gz | 221.4 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9fjf.ent.gz | 173.6 KB | Display | PDB format |
| PDBx/mmJSON format | 9fjf.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 9fjf_validation.pdf.gz | 532.4 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 9fjf_full_validation.pdf.gz | 539.2 KB | Display | |
| Data in XML | 9fjf_validation.xml.gz | 22.3 KB | Display | |
| Data in CIF | 9fjf_validation.cif.gz | 35.1 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/fj/9fjf ftp://data.pdbj.org/pub/pdb/validation_reports/fj/9fjf | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 50502MC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
-Protein , 2 types, 2 molecules AB
| #1: Protein | Mass: 44862.691 Da / Num. of mol.: 1 Mutation: aa 36-431; N-terminal IgK leader; C-terminal TEV site and 10xHis tag Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: SCARB2, CD36L2, LIMP2, LIMPII / Plasmid: pCMV3_IgK-sLIMP-2-10xHis / Details (production host): pCMV3 backbone / Cell line (production host): HEK 293F / Production host: Homo sapiens (human) / References: UniProt: Q14108 |
|---|---|
| #2: Protein | Mass: 55659.219 Da / Num. of mol.: 1 / Mutation: none Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: GBA, GC, GLUC / Plasmid: pCMV3_GBA1 / Details (production host): Sino Biological; #HG12038-UT / Cell line (production host): HEK 293F / Production host: Homo sapiens (human)References: UniProt: P04062, glucosylceramidase, Transferases; Glycosyltransferases; Hexosyltransferases, EC: 3.2.1.104 |
-Antibody , 2 types, 2 molecules CD
| #3: Antibody | Mass: 14409.816 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: Pro-Macrobody; nanobody fused to maltose-binding protein (MBP) via Pro-Pro linker; MBP not resolved and not modeled. Source: (gene. exp.) synthetic construct (others) / Production host: ![]() |
|---|---|
| #4: Antibody | Mass: 13145.612 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: Pro-Macrobody; nanobody fused to maltose-binding protein (MBP) via Pro-Pro linker; MBP not resolved and not modeled. Source: (gene. exp.) synthetic construct (others) / Production host: ![]() |
-Sugars , 4 types, 13 molecules 
| #5: Polysaccharide | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta- ...beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source | ||||
|---|---|---|---|---|---|
| #6: Polysaccharide | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source #7: Polysaccharide | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2- ...alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | Source method: isolated from a genetically manipulated source #8: Sugar | ChemComp-NAG / |
-Non-polymers , 2 types, 31 molecules 


| #9: Chemical | ChemComp-MES / #10: Water | ChemComp-HOH / | |
|---|
-Details
| Has ligand of interest | N |
|---|---|
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Lysosomal transporting complex of beta-glucocerebrosidase and lysosomal integral membrane protein 2 (LIMP-2) with two bound Pro-macrobodies. Type: COMPLEX Details: Maltose-binding protein (MBP) domains of Pro-macrobodies were not resolved, only nanobody domains are included in the model. Entity ID: #2, #4, #1, #3 / Source: RECOMBINANT | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight | Value: 0.25 MDa / Experimental value: NO | |||||||||||||||
| Source (natural) | Organism: Homo sapiens (human) | |||||||||||||||
| Source (recombinant) | Organism: hybrid (others) | |||||||||||||||
| Buffer solution | pH: 7.4 / Details: 20 mM MES; 150 mM NaCl, pH: 7.4 | |||||||||||||||
| Buffer component |
| |||||||||||||||
| Specimen | Conc.: 0.6 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES Details: Monodisperse, complex seperated from monomers via size exclusion chhromatography. | |||||||||||||||
| Specimen support | Details: Protochips; CF-1.2/1.3-3Cu-50 / Grid material: COPPER / Grid mesh size: 300 divisions/in. / Grid type: C-flat-1.2/1.3 | |||||||||||||||
| Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE / Humidity: 100 % / Chamber temperature: 277 K |
-
Electron microscopy imaging
| Microscopy | Model: TFS GLACIOS |
|---|---|
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 200 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 130000 X / Nominal defocus max: 2000 nm / Nominal defocus min: 600 nm |
| Specimen holder | Cryogen: NITROGEN |
| Image recording | Electron dose: 50 e/Å2 / Detector mode: COUNTING / Film or detector model: FEI FALCON IV (4k x 4k) / Num. of grids imaged: 1 / Num. of real images: 10550 |
| EM imaging optics | Energyfilter name: TFS Selectris / Energyfilter slit width: 10 eV |
-
Processing
| EM software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Symmetry | Point symmetry: C1 (asymmetric) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3D reconstruction | Resolution: 3.7 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 397385 / Symmetry type: POINT | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Atomic model building |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Atomic model building | Source name: PDB / Type: experimental model
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
United States, 5items
Citation




PDBj







gel filtration



